mycophenolateglucocorticoidsSSc-pHIsystemic sclerosis (SSc)SSc
… immunosuppression (61%), while most chronic pHI (67%) received mycophenolate monotherapy.Conclusions Active SSc-pHI is associated with worse…
37articles mentioning drugs
67drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: mycophenolate ×
mycophenolate
This drug is selected. Its supporting articles are shown below.
Articles mentioning mycophenolate
37 articles · page 2 of 496.1%
nifedipinetocilizumabmycophenolaterituximabprednisoloneintravenous methylprednisoloneScleroderma cardiac crisissystemic sclerosis (SSc)cardioprotective treatment
…ment with low dose prednisolone, mycophenolate, tocilizumab and nifedipine with partial control of her disease. She was on regular follow-…
nerandomilastnintedanibPrednisonemycophenolaterituximabtocilizumabCyclophosphamideSSc-ILD
…in 4 (17.4%), 7 (28.0%) and 11 (40.7%) patients in the placebo, nerandomilast 9 mg and 18 mg BID groups, respectively. Rates of treatment dis…
methotrexatemycophenolateMTXMMFsystemic sclerosisSSc
…e most prescribed IS in ACA- (47%), mainly for ILD (82%), while methotrexate (MTX) predominated in ACA+ (53%), used for cutaneous (44%) or a…
rituximabmethotrexatemycophenolatemyocphenolatecyclophosphamideHealth Assessment QuestionnaireVisual Analogue Scalesystemic sclerosis (SSc)European Scleroderma Study GroupSt George's Respiratory Questionnaire+1 more
…SF-36).Conclusions These findings suggest that long-term use of rituximab provides sustained clinical benefit in patients with progressiv…
rituximabMMF-RTXmycophenolate mofetilMMFRTX-MMFmycophenolateRTX
…nation treatment with mycophenolate and rituximab (MMF-RTX) vs. rituximab monotherapy (RTX) in a single-center cohort of patients affecte…
cyclophosphamidemycophenolatemethotrexatecancerSSc
…LR3 (19% vs 8%; p=0.03).Subsequent cancers were associated with cyclophosphamide (OR 2.6; CI 1.5-4.7), negatively with mycophenolate (OR 0.4; CI…
mycophenolatecyclophosphamidegonadotropin-releasing hormone agonistsSusac syndromeSuSfertility-preserving treatment
…se control, she conceived spontaneously following withdrawal of mycophenolate and went on to have an uneventful pregnancy and postpartum peri…
93.6%
nintedanibmycophenolateAntifibrotic therapyidiopathic pulmonary fibrosistertiary hospitalDiffuse interstitial lung diseases (DILD)sclerodermaPFLDIPFprogressive fibrosing lung disease (PFLD)
…ype with functional decline. Antifibrotic therapy, particularly nintedanib, has significantly improved management by slowing forced vital …
belimumabhydroxychloroquinecyclophosphamiderituximabmethotrexatemycophenolateazathioprineprednisoneSystemic lupus erythematosusRheumatology Department+2 more
…ease with highly variable manifestations. New therapies such as belimumab appear to reduce cumulative organ damage and disease flares, im…
belimumabmycophenolatecalcineurin inhibitorsLupus podocytopathynephrotic syndromesystemic lupus erythematosusSLEcorticosteroid therapyFSGSMCD
…essants: calcineurin inhibitors (3/5), mycophenolate (2/5), and belimumab (1/5). The most frequent extrarenal manifestations were arthrit…
90.2%
mycophenolate mofetilvoclosporinvalganciclovirTrimethoprim-sulfamethoxazoleempagliflozintelmisartanatorvastatincyclophosphamiderituximabhydroxychloroquine+3 more
…ximab, and plasmapheresis, followed by maintenance therapy with mycophenolate mofetil and voclosporin, can result in significant renal and pulmonary …